Earlier this month, Aetna entered into a definitive agreement to acquire Humana in a deal valued at $37 billion. Under the deal, Humana stockholders will receive $125 in cash and 0.8375 Aetna common shares for each Humana share.
However, Maureen Scott, the lead plaintiff in the lawsuit, claims the deal undervalues Humana and accuses Humana and its board of directors of breaching their fiduciary duty to shareholders by agreeing to the deal, according to the report.
Ms. Scott also claims the Aetna-Humana deal underestimates the antitrust hurdles ahead.
The case is pending in Delaware Chancery Court.
More articles on healthcare industry lawsuits:
7 latest healthcare industry lawsuits
Physician receives 45-year sentence for administering chemotherapy to healthy patients
Florida Hospital hit with two data breach lawsuits
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.